Home ETF List About

Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / FundiShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
IssuerBlackrock
Entity holding fund iShares VII Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF TickerCUS1(GBX) LSE
ETF TickerCUSS(USD) LSE
ETF TickerSXRG(EUR) F
ETF TickerCSUSS.MI(EUR) CXE
ETF TickerCSUSSz(USD) CXE
ETF TickerCUSS.LS(USD) CXE
ETF TickerCSUSS(EUR) ETF Plus
ETF TickerCUS1.L(GBP) LSE
ETF TickerCUSS.L(GBP) LSE

Holdings detail for JAZZ

Stock NameJazz Pharmaceuticals PLC
TickerJAZZ(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINIE00B4Q5ZN47

Show aggregate JAZZ holdings

News associated with JAZZ

Jazz Pharmaceuticals (NASDAQ:JAZZ) Price Target Raised to $185.00
Jazz Pharmaceuticals (NASDAQ:JAZZ – Free Report) had its price target hoisted by The Goldman Sachs Group from $162.00 to $185.00 in a research report report published on Friday morning,Benzinga reports. The Goldman Sachs Group currently has a buy rating on the specialty pharmaceutical company’s stock. A number of other research analysts also recently commented on […] - 2025-09-01 02:59:05
Implied FSMD Analyst Target Price: $49
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-08-21 10:25:46
Brokerages Set Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) Target Price at $181.43
Shares of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ – Get Free Report) have been given an average recommendation of “Moderate Buy” by the fourteen brokerages that are covering the firm, Marketbeat reports. One analyst has rated the stock with a hold recommendation and thirteen have assigned a buy recommendation to the company. The average 1 year target […] - 2025-08-19 03:06:58
Swiss National Bank Trims Stock Position in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)
Swiss National Bank decreased its position in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ – Free Report) by 3.6% in the first quarter, Holdings Channel reports. The firm owned 111,300 shares of the specialty pharmaceutical company’s stock after selling 4,100 shares during the period. Swiss National Bank’s holdings in Jazz Pharmaceuticals were worth $13,818,000 at the end of […] - 2025-08-15 05:24:55
Vanguard Group Inc. Has $747.06 Million Stake in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)
Vanguard Group Inc. trimmed its holdings in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ – Free Report) by 0.3% in the first quarter, Holdings Channel reports. The institutional investor owned 6,017,403 shares of the specialty pharmaceutical company’s stock after selling 18,780 shares during the period. Vanguard Group Inc. owned approximately 0.10% of Jazz Pharmaceuticals worth $747,061,000 at the […] - 2025-08-13 06:14:46
Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) Shares Purchased by PNC Financial Services Group Inc.
PNC Financial Services Group Inc. lifted its position in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ – Free Report) by 8.0% in the 1st quarter, HoldingsChannel.com reports. The firm owned 5,128 shares of the specialty pharmaceutical company’s stock after acquiring an additional 379 shares during the quarter. PNC Financial Services Group Inc.’s holdings in Jazz Pharmaceuticals were worth […] - 2025-08-13 04:38:53
Cetera Investment Advisers Purchases 444 Shares of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)
Cetera Investment Advisers increased its position in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ – Free Report) by 4.4% during the first quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 10,536 shares of the specialty pharmaceutical company’s stock after purchasing an additional 444 shares during the quarter. Cetera Investment […] - 2025-08-11 04:18:46
Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) Shares Sold by Allianz Asset Management GmbH
Allianz Asset Management GmbH lessened its stake in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ – Free Report) by 24.9% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 58,745 shares of the specialty pharmaceutical company’s stock after selling 19,447 shares during the quarter. […] - 2025-07-28 04:36:57
Y Intercept Hong Kong Ltd Grows Stake in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)
Y Intercept Hong Kong Ltd increased its holdings in shares of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ – Free Report) by 269.5% in the 1st quarter, HoldingsChannel.com reports. The firm owned 9,721 shares of the specialty pharmaceutical company’s stock after acquiring an additional 7,090 shares during the period. Y Intercept Hong Kong Ltd’s holdings in Jazz Pharmaceuticals […] - 2025-07-25 06:11:00
Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) Receives $181.71 Consensus Price Target from Analysts
Shares of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the fourteen ratings firms that are presently covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the company. The average […] - 2025-07-25 04:35:13
Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) Shares Acquired by Xponance Inc.
Xponance Inc. raised its position in shares of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ – Free Report) by 8.2% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 8,594 shares of the specialty pharmaceutical company’s stock after acquiring an additional 648 shares during the […] - 2025-07-17 07:42:48
Jazz Pharmaceuticals (NASDAQ:JAZZ) Now Covered by Deutsche Bank Aktiengesellschaft
Analysts at Deutsche Bank Aktiengesellschaft initiated coverage on shares of Jazz Pharmaceuticals (NASDAQ:JAZZ – Get Free Report) in a research report issued to clients and investors on Tuesday, Marketbeat.com reports. The brokerage set a “buy” rating and a $152.00 price target on the specialty pharmaceutical company’s stock. Deutsche Bank Aktiengesellschaft’s price objective indicates a potential […] - 2025-07-17 06:19:01
Cerity Partners LLC Acquires 4,744 Shares of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)
Cerity Partners LLC raised its holdings in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ – Free Report) by 14.3% during the 1st quarter, Holdings Channel.com reports. The institutional investor owned 37,949 shares of the specialty pharmaceutical company’s stock after acquiring an additional 4,744 shares during the quarter. Cerity Partners LLC’s holdings in Jazz Pharmaceuticals were worth $4,711,000 at […] - 2025-07-17 05:00:57
State of Michigan Retirement System Has $1.80 Million Stock Position in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)
State of Michigan Retirement System increased its stake in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ – Free Report) by 1.4% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 14,504 shares of the specialty pharmaceutical company’s stock after buying an additional 200 shares […] - 2025-07-15 06:28:18
Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) Shares Acquired by OneDigital Investment Advisors LLC
OneDigital Investment Advisors LLC grew its stake in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ – Free Report) by 10.6% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,932 shares of the specialty pharmaceutical company’s stock after buying an additional 377 shares during […] - 2025-07-11 07:30:53
Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) Shares Sold by Teacher Retirement System of Texas
Teacher Retirement System of Texas reduced its holdings in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ – Free Report) by 10.9% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 15,470 shares of the specialty pharmaceutical company’s stock after selling 1,902 shares during the quarter. Teacher Retirement System […] - 2025-07-11 05:14:57
Vontobel Holding Ltd. Lowers Holdings in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)
Vontobel Holding Ltd. trimmed its holdings in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ – Free Report) by 15.5% in the 1st quarter, according to its most recent disclosure with the SEC. The firm owned 3,577 shares of the specialty pharmaceutical company’s stock after selling 656 shares during the period. Vontobel Holding Ltd.’s holdings in Jazz Pharmaceuticals were […] - 2025-07-08 05:30:53
Allspring Global Investments Holdings LLC Sells 489 Shares of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)
Allspring Global Investments Holdings LLC trimmed its holdings in shares of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ – Free Report) by 3.1% during the first quarter, Holdings Channel.com reports. The fund owned 15,129 shares of the specialty pharmaceutical company’s stock after selling 489 shares during the quarter. Allspring Global Investments Holdings LLC’s holdings in Jazz Pharmaceuticals were […] - 2025-07-08 04:32:49
Envestnet Portfolio Solutions Inc. Buys 1,223 Shares of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)
Envestnet Portfolio Solutions Inc. raised its holdings in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ – Free Report) by 38.9% during the 1st quarter, HoldingsChannel.com reports. The fund owned 4,369 shares of the specialty pharmaceutical company’s stock after buying an additional 1,223 shares during the period. Envestnet Portfolio Solutions Inc.’s holdings in Jazz Pharmaceuticals were worth $542,000 at […] - 2025-06-27 05:08:51
15,296 Shares in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Acquired by Ritholtz Wealth Management
Ritholtz Wealth Management bought a new position in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 15,296 shares of the specialty pharmaceutical company’s stock, valued at approximately $1,899,000. A number of other […] - 2025-06-17 07:00:52
Yousif Capital Management LLC Decreases Stock Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)
Yousif Capital Management LLC cut its holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 2.6% in the first quarter, HoldingsChannel reports. The institutional investor owned 12,644 shares of the specialty pharmaceutical company’s stock after selling 342 shares during the quarter. Yousif Capital Management LLC’s holdings in Jazz Pharmaceuticals were worth $1,570,000 as of […] - 2025-06-17 05:08:52
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Shares Purchased by Wealth Enhancement Advisory Services LLC
Wealth Enhancement Advisory Services LLC raised its stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 22.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,102 shares of the specialty pharmaceutical company’s stock after purchasing an additional 743 shares during […] - 2025-06-13 04:34:51
2,265 Shares in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Purchased by Merit Financial Group LLC
Merit Financial Group LLC bought a new position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) in the 1st quarter, Holdings Channel.com reports. The institutional investor bought 2,265 shares of the specialty pharmaceutical company’s stock, valued at approximately $281,000. Several other large investors have also recently modified their holdings of JAZZ. IFP Advisors Inc bought […] - 2025-06-12 05:32:55
Wedmont Private Capital Sells 903 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ)
Wedmont Private Capital trimmed its position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 13.3% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 5,912 shares of the specialty pharmaceutical company’s stock after selling 903 shares during the period. […] - 2025-06-10 05:33:02
Focus Partners Wealth Invests $551,000 in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)
Focus Partners Wealth bought a new position in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) in the fourth quarter, HoldingsChannel reports. The institutional investor bought 4,469 shares of the specialty pharmaceutical company’s stock, valued at approximately $551,000. A number of other hedge funds also recently modified their holdings of the stock. Bessemer Group […] - 2025-05-20 07:12:52
How The Pieces Add Up: IJH Headed For $69
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-05-19 07:58:47
Hsbc Holdings PLC Acquires 605 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ)
Hsbc Holdings PLC boosted its holdings in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 26.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,871 shares of the specialty pharmaceutical company’s stock after buying an additional 605 […] - 2025-05-09 05:34:54
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Stock Position Raised by Townsquare Capital LLC
Townsquare Capital LLC lifted its position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 79.5% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 3,540 shares of the specialty pharmaceutical company’s stock after buying an additional 1,568 shares during the quarter. Townsquare […] - 2025-04-21 05:00:54
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Shares Sold by Bank of Montreal Can
Bank of Montreal Can reduced its position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 11.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 17,194 shares of the specialty pharmaceutical company’s stock after selling 2,253 shares during the period. Bank of […] - 2025-04-17 05:42:52
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Shares Sold by Wells Fargo & Company MN
Wells Fargo & Company MN lessened its holdings in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 17.1% during the fourth quarter, HoldingsChannel reports. The fund owned 96,952 shares of the specialty pharmaceutical company’s stock after selling 20,063 shares during the period. Wells Fargo & Company MN’s holdings in Jazz Pharmaceuticals were worth […] - 2025-04-16 05:27:14

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc JAZZ holdings

DateNumber of JAZZ Shares HeldBase Market Value of JAZZ SharesLocal Market Value of JAZZ SharesChange in JAZZ Shares HeldChange in JAZZ Base ValueCurrent Price per JAZZ Share HeldPrevious Price per JAZZ Share Held
2025-09-26 (Friday)30,676USD 3,895,852USD 3,895,852
2025-09-25 (Thursday)30,676USD 3,920,393JAZZ holding decreased by -54910USD 3,920,3930USD -54,910 USD 127.8 USD 129.59
2025-09-24 (Wednesday)30,676USD 3,975,303USD 3,975,303
2025-09-17 (Wednesday)30,478JAZZ holding increased by 967USD 3,948,120JAZZ holding increased by 213798USD 3,948,120967USD 213,798 USD 129.54 USD 126.54
2025-09-16 (Tuesday)29,511USD 3,734,322USD 3,734,322
2025-09-12 (Friday)29,319USD 3,698,885USD 3,698,885
2025-09-11 (Thursday)29,319USD 3,766,319USD 3,766,319
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of JAZZ by Blackrock for IE00B3VWM098

Show aggregate share trades of JAZZ

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-09-17BUY967 129.540* 118.03
2025-08-21SELL-94 120.530* 118.01 Profit of 11,093 on sale
2025-07-31BUY291 114.630* 118.03
2025-07-28SELL-97 117.375* 118.05 Profit of 11,451 on sale
2025-06-30SELL-194 106.120* 118.74 Profit of 23,037 on sale
2025-06-25SELL-97 107.120* 118.99 Profit of 11,542 on sale
2025-06-20SELL-194 107.510* 119.23 Profit of 23,132 on sale
2025-05-19SELL-97 109.780* 121.31 Profit of 11,767 on sale
2025-05-15SELL-291 106.070* 121.55 Profit of 35,371 on sale
2025-05-12SELL-97 103.580* 122.01 Profit of 11,835 on sale
2025-05-09SELL-97 97.780* 122.23 Profit of 11,857 on sale
2025-04-30SELL-97 116.960* 122.94 Profit of 11,925 on sale
2025-04-24SELL-194 108.980* 123.37 Profit of 23,933 on sale
2025-04-17SELL-97 102.780* 124.47 Profit of 12,073 on sale
2025-04-15SELL-291 102.910* 124.95 Profit of 36,360 on sale
2025-04-14SELL-291 101.750* 125.20 Profit of 36,435 on sale
2025-04-09SELL-388 110.120* 125.92 Profit of 48,857 on sale
2025-04-07SELL-679 106.930* 126.41 Profit of 85,832 on sale
2025-04-04SELL-970 110.040* 126.60 Profit of 122,804 on sale
2025-03-31BUY97 124.150* 126.65
2025-03-19SELL-194 142.070* 125.77 Profit of 24,399 on sale
2025-03-14SELL-582 137.960* 125.20 Profit of 72,865 on sale
2025-03-13SELL-188 136.050* 125.04 Profit of 23,508 on sale
2025-03-12SELL-1,921 134.160* 124.91 Profit of 239,953 on sale
2025-03-07SELL-188 138.810* 124.33 Profit of 23,374 on sale
2025-03-06SELL-282 136.450* 124.14 Profit of 35,008 on sale
2025-03-03SELL-94 140.220* 123.38 Profit of 11,598 on sale
2025-02-28BUY3,521 143.530* 123.05
2025-02-26SELL-83 144.170* 122.35 Profit of 10,155 on sale
2025-02-25SELL-249 139.670* 122.06 Profit of 30,392 on sale
2025-02-18BUY415 135.390* 120.75
2025-02-13BUY83 136.820* 119.90
2025-02-12BUY83 135.440* 119.58
2025-02-11BUY249 129.980* 119.36
2025-02-06BUY747 120.070* 119.23
2025-01-27BUY83 124.390* 118.34
2024-12-30BUY415 122.970* 117.80
2024-12-06BUY332 122.590* 117.46
2024-12-05BUY83 123.140* 117.27
2024-12-04BUY415 123.450* 117.05
2024-11-29BUY415 121.590* 116.50
2024-11-27BUY332 122.640* 115.97
2024-11-26BUY83 122.790* 115.66
2024-11-25BUY1,295 124.340* 115.24
2024-11-21BUY395 125.100* 114.12
2024-11-20BUY237 119.240* 113.84
2024-11-18BUY948 117.590* 113.42
2024-11-12BUY632 127.740* 112.46
2024-11-08BUY395 123.610* 111.67
2024-11-07BUY1,185 119.080* 111.10
2024-11-06BUY158 111.550* 111.06
2024-10-31BUY79 110.030* 111.43
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of JAZZ

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19112,0730208,47353.8%
2025-09-18174,5630259,89967.2%
2025-09-17181,8670321,52256.6%
2025-09-16144,278295264,73354.5%
2025-09-15104,62110235,85544.4%
2025-09-12204,4370280,69872.8%
2025-09-11110,76958388,04628.5%
2025-09-1095,5500204,76846.7%
2025-09-09105,9465218,51748.5%
2025-09-08114,18473205,78555.5%
2025-09-05176,4669300,43758.7%
2025-09-04217,8760386,09256.4%
2025-09-03159,0990265,39659.9%
2025-09-02245,7661,378345,99171.0%
2025-08-29188,3790252,58274.6%
2025-08-28166,3862,760218,63676.1%
2025-08-27141,87022,558195,62072.5%
2025-08-26217,58511,530291,59674.6%
2025-08-25225,1700314,43071.6%
2025-08-22135,885193263,62851.5%
2025-08-21107,180329288,39037.2%
2025-08-20145,7890282,57551.6%
2025-08-19211,5460381,13255.5%
2025-08-18136,13058223,19661.0%
2025-08-15114,7780190,46760.3%
2025-08-14125,1240224,73055.7%
2025-08-13265,70315,414607,34343.7%
2025-08-12124,71515276,80545.1%
2025-08-11149,9300300,25049.9%
2025-08-08152,8104,111258,68459.1%
2025-08-07456,871104781,30558.5%
2025-08-06788,262311,198,16265.8%
2025-08-05177,95542421,69942.2%
2025-08-04124,63010224,65555.5%
2025-08-01144,0394220,46065.3%
2025-07-3181,90375163,02050.2%
2025-07-3070,56718141,25450.0%
2025-07-2995,30413189,72250.2%
2025-07-2886,23241165,16852.2%
2025-07-25100,3350159,54162.9%
2025-07-24104,03110197,57552.7%
2025-07-2389,333413211,21342.3%
2025-07-22245,6424,000510,58448.1%
2025-07-21115,06522156,57973.5%
2025-07-18143,3240210,98367.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.